April 30, 2024
Medical innovations don’t happen overnight — but in today’s digital world, they happen pretty fast. Some are advancing faster than you think. We’re not talking theory […]
April 30, 2024
On April 29, 2024, The US Food and Drug Administration (FDA) has accepted a Supplemental New Drug Application for tapinarof cream, 1%, for the topical treatment […]
April 30, 2024
In the setting of conflicting national screening guidelines, the incidence of distant- and regional-stage colorectal adenocarcinoma (CRC) has been increasing in individuals aged 46-49 years, a […]
April 30, 2024
Share on PinterestJournalist Maria Shriver wants women to understand their risk of Alzheimer’s disease. Gabe Ginsberg/Getty Images Journalist and advocate Maria Shriver is sharing her latest […]
April 30, 2024
Share on PinterestAs bird flu spreads among cattle and poultry, is it safe to eat beef and chicken? Guido Mieth/Getty Images Avian influenza (bird flu) has […]
April 29, 2024
The Inactive Ingredients files are supplied as comma delimited text and Excel files. The size of each unzipped file is less than 2 MB. We update […]
April 29, 2024
Tivdak (tisotumab vedotin-tftv) Treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy 9/20/2021 4/29/2024 Elahere (mirvetuximab soravtansine-gynx) Adult […]
April 29, 2024
On April 29, 2024, the Food and Drug Administration granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) for recurrent […]
April 29, 2024
2024 2023 2022 2021 2020 2019 Understanding the Change Log Welcome to the Quarterly IID Change Log. FDA publishes the IID on a quarterly basis. The […]